drugset / Trial / NCT02750917

Lornoxicam Versus Etoricoxib in Postoperative Pain After Total Knee Arthroplasty

NCT02750917

Phase 3 Completed 120 enrolled Foisor Orthopedics Clinical Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess efficacy and safety of lornoxicam compared with that of etoricoxib after total knee replacement.

Timeline

Start
2014-09
Primary completion
2015-01
Completion
2015-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Etoricoxib Small molecule 120 mg Oral
Subject Lornoxicam Small molecule 8 mg Oral

Indications

No indication recorded.